Site Under Construction

HIV and leprosy in a 27-year-old Filipino male: A case report

Kristen Therese A. Whaley, MD, Ma. Teresita G. Gabriel, MD, FPDS, Emmanuel Jacinth C. Atienza, MD



Hansen’s disease or leprosy is a chronic infectious disease caused by Mycobacterium leprae associated with inflammation that may damage the skin and peripheral nerves. In countries where leprosy is still endemic, an increasing prevalence of human immunodeficiency virus (HIV) can be seen, hence increasing the possibility of HIV-leprosy co-infection. Hansen’s disease, if not treated promptly, can cause scars and deformities associated with leprosy reaction. Immunosuppressive drugs like corticosteroids used in the treatment of leprosy reaction may put the patient at risk of opportunistic infections.


Case Report

This is a case of a 27-year-old Filipino male with HIV-leprosy co-infection, who manifested with erythema nodosum leprosum reaction, treated with tapering dose of oral corticosteroids and multidrug therapy (MDT) for multibacillary leprosy showing good response to treatment after 5 months without recurrence of reaction. The use of chronic oral corticosteroids, despite its immunosuppressive effects, has been beneficial in the management of reactions in this patient with HIV-leprosy co-infection.



Considering that both Hansen’s disease and HIV directly affects T helper CD4+ lymphocytes in its pathogenesis, there seems to be little to no alteration in the course of patients with HIV-leprosy co-infection. Hence, treatment of HIV-leprosy co-infection does not differ from that of a seronegative leprosy patient. This case highlights the occurrence of erythema nodosum leprosum reaction in HIV-leprosy co-infection and the need for immunosuppressive drugs to control reaction and prevent nerve damage. Close monitoring is imperative to weigh the risk-benefit ratio of medications given to patients with HIV-leprosy co-infection.


  1. Pires CA, Jucá Neto FO, de Albuquerque NC, Macedo GM, Batista Kde N, Xavier MB. Leprosy Reactions in Patients Coinfected with HIV: Clinical
    Aspects and Outcomes in Two Comparative Cohorts in the Amazon Region, Brazil. PLoS Negl Trop Dis. 2015 Jun 1;9(6):e0003818. doi: 10.1371/
    journal.pntd.0003818. PMID: 26029928; PMCID: PMC4451982.
  2. Scollard DM, Gillis TP, et al. The International Textbook of Leprosy. 1st ed. American Leprosy Missions; 2019.
  3. Camaclang, MLA. and Cubillan, ELA. Lepromatous Leprosy and Human Immunodeficiency Virus: A Rare Co-infection. Acta Medica Philippina. 53.2.177-180.
  4. Deps P, Lockwood DN. Leprosy presenting as immune reconstitution inflammatory syndrome: proposed definitions and classification. Lepr Rev. 2010 Mar;81(1):59-68. PMID: 20496570.
  5. Serrano-Coll H, Beltrán-Alzate J, Buitrago, S, Cardona-Castro N. Lepromatous leprosy and human immunodeficiency virus co-infection associated with phenomenon of Lucio versus immune reconstitution inflammatory syndrome. Infectio. 20. 10.1016/j.infect.2015.10.011.
  6. Xavier MB, do Nascimento MGB, Batista K de NM, Somensi DN, Juca Neto FOM, Carneiro TX, et al. Peripheral nerve abnormality in HIV leprosy
    patients. PLOS Neglected Tropical Diseases, 12(7), e0006633. doi:10.1371/journal.pntd.0006633

REquesting Permission

HIV and leprosy in a 27-year-old Filipino male: A case report